TL;DR
Low NCALD expression was associated with reduced sensitivity to platinum-based chemotherapy, and may be a new biomarker candidate to identify patients who might benefit from platinum- based chemotherapy.
AI-generated by Semantic Scholar
Authors
Sarah M Konrad, Kristina Schwamborn, Achim Krüger, Katja Honert, Manfred Schmitt, Daniela Hellmann, Barbara Schmalfeldt, Alfons Meindl, Marion Kiechle, Anne S Quante, Christine Brambs, Sabine Grill, Juliane Ramser
